QBiotics Group launches new website

January, 2018 Update

We have now launched a new website for QBiotics Group. The website is designed to reflect ... read more

Patient recruitment for tigilanol tiglate trials in USA completed

January, 2018 Update

In late December, we finalised patient recruitment for the US tigilanol tiglate mast cell tumour veterinary pivotal field efficacy study with the required 120 dogs now recruited ... read more

EBC-46 (tigilanol tiglate) pivotal trials in the USA and EU show significant progress

October, 2017 Update

Veterinary development of tigilanol tiglate is progressing well.
Dogs recruited on the USA FDA Centre for Veterinary ... read more